Ocular manifestations in newly diagnosed acute leukemia: diagnostic performance of age, hemoglobin and platelets for retinal haemorrhages.

Ali Fettah, Volkan Köse, Aslıhan Yüce Sezen, Caner Kara, Onur Mert Çelik, Fatma Tuba Yıldırım
{"title":"Ocular manifestations in newly diagnosed acute leukemia: diagnostic performance of age, hemoglobin and platelets for retinal haemorrhages.","authors":"Ali Fettah, Volkan Köse, Aslıhan Yüce Sezen, Caner Kara, Onur Mert Çelik, Fatma Tuba Yıldırım","doi":"10.24953/turkjpediatr.2026.7154","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ocular involvement in the diagnosis of leukemia is clinically important but has been reported variably. Our aim was to define its prevalence and spectrum and to identify hematologic predictors, specifically age, hemoglobin level (Hb), platelet count (PLT), mean platelet volume (MPV), and platelet mass index (PMI).</p><p><strong>Methods: </strong>This retrospective, single-center study evaluated all newly diagnosed leukemia patients between January 2023 and March 2025. All patients were examined by an ophthalmologist at the time of diagnosis and, if present, ocular involvement was identified.</p><p><strong>Results: </strong>Among 78 pediatric patients, ocular involvement was present in 17 of 78 patients (21.8%). The most common ocular manifestation was retinal hemorrhage (16.7%). Ocular involvement was more frequent in acute myeloid leukemia (AML) than in acute lymphoblastic leukemia (ALL) (46.7% vs. 15.9%, p= 0.016). Older age (for ocular involvement: median 13 years [6-15] vs. 5 years [3-11], p = 0.006; for retinal hemorrhage: median 14 years [10-15] vs. 5 years [3-11], p = 0.001) and lower hemoglobin (for ocular involvement: 6.68 ± 2.31 g/dL vs. 8.46 ± 2.47 g/dL, p = 0.01; for retinal hemorrhage: 6.33 ± 2.26 g/dL vs. 8.43 ± 2.46 g/dL, p= 0.006) were associated with a higher risk. In multivariate models, age and Hb were independent predictors of hemorrhage (age: odds ratio [OR] 1.29, 95% confidence interval [CI] 1.10-1.52 per year; Hb: OR 0.60, 95% CI 0.38-0.95 per g/dL). ROC analyses showed that age provided the best discrimination (area under the curve [AUC] 0.796; 95% CI 0.651-0.940; cut-off ≥10 years: 73% sensitivity, 70% specificity), followed by Hb (AUC 0.756; 95% CI 0.604-0.908; cut-off 6.95 g/dL: sensitivity 76%, specificity 76%), whereas PLT showed weaker discrimination (AUC 0.682; 95% CI 0.553-0.812; cut-off 48,000/mm³: sensitivity 62%, specificity 65%).</p><p><strong>Conclusion: </strong>Approximately one in five children had ocular involvement at diagnosis, most commonly retinal hemorrhage. Age and hemoglobin independently predicted retinal hemorrhage and provided useful discrimination. These data support a \"hemoglobin-first\" triage that prioritizes initial and follow-up ocular fundus testing in older children and those with an Hb ≲7 g/dL, with external validation of the proposed thresholds warranted.</p>","PeriodicalId":101314,"journal":{"name":"The Turkish journal of pediatrics","volume":"68 3","pages":"450-460"},"PeriodicalIF":0.0000,"publicationDate":"2026-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Turkish journal of pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24953/turkjpediatr.2026.7154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Ocular involvement in the diagnosis of leukemia is clinically important but has been reported variably. Our aim was to define its prevalence and spectrum and to identify hematologic predictors, specifically age, hemoglobin level (Hb), platelet count (PLT), mean platelet volume (MPV), and platelet mass index (PMI).

Methods: This retrospective, single-center study evaluated all newly diagnosed leukemia patients between January 2023 and March 2025. All patients were examined by an ophthalmologist at the time of diagnosis and, if present, ocular involvement was identified.

Results: Among 78 pediatric patients, ocular involvement was present in 17 of 78 patients (21.8%). The most common ocular manifestation was retinal hemorrhage (16.7%). Ocular involvement was more frequent in acute myeloid leukemia (AML) than in acute lymphoblastic leukemia (ALL) (46.7% vs. 15.9%, p= 0.016). Older age (for ocular involvement: median 13 years [6-15] vs. 5 years [3-11], p = 0.006; for retinal hemorrhage: median 14 years [10-15] vs. 5 years [3-11], p = 0.001) and lower hemoglobin (for ocular involvement: 6.68 ± 2.31 g/dL vs. 8.46 ± 2.47 g/dL, p = 0.01; for retinal hemorrhage: 6.33 ± 2.26 g/dL vs. 8.43 ± 2.46 g/dL, p= 0.006) were associated with a higher risk. In multivariate models, age and Hb were independent predictors of hemorrhage (age: odds ratio [OR] 1.29, 95% confidence interval [CI] 1.10-1.52 per year; Hb: OR 0.60, 95% CI 0.38-0.95 per g/dL). ROC analyses showed that age provided the best discrimination (area under the curve [AUC] 0.796; 95% CI 0.651-0.940; cut-off ≥10 years: 73% sensitivity, 70% specificity), followed by Hb (AUC 0.756; 95% CI 0.604-0.908; cut-off 6.95 g/dL: sensitivity 76%, specificity 76%), whereas PLT showed weaker discrimination (AUC 0.682; 95% CI 0.553-0.812; cut-off 48,000/mm³: sensitivity 62%, specificity 65%).

Conclusion: Approximately one in five children had ocular involvement at diagnosis, most commonly retinal hemorrhage. Age and hemoglobin independently predicted retinal hemorrhage and provided useful discrimination. These data support a "hemoglobin-first" triage that prioritizes initial and follow-up ocular fundus testing in older children and those with an Hb ≲7 g/dL, with external validation of the proposed thresholds warranted.

新诊断急性白血病的眼部表现:年龄、血红蛋白和血小板对视网膜出血的诊断表现。
背景:眼部受累对白血病的诊断具有重要的临床意义,但已有不同的报道。我们的目的是确定其患病率和频谱,并确定血液学预测因子,特别是年龄,血红蛋白水平(Hb),血小板计数(PLT),平均血小板体积(MPV)和血小板质量指数(PMI)。方法:这项回顾性、单中心研究评估了2023年1月至2025年3月期间所有新诊断的白血病患者。所有患者在诊断时都由眼科医生检查,如果存在,则确定眼部受累。结果:78例患儿中有17例(21.8%)出现眼部受累。最常见的眼部表现为视网膜出血(16.7%)。急性髓性白血病(AML)的眼部受累发生率高于急性淋巴细胞白血病(ALL)(46.7%比15.9%,p= 0.016)。年龄较大(眼部受累:中位年龄为13岁[6-15]vs. 5岁[3-11],p= 0.006;视网膜出血:中位年龄为14岁[10-15]vs. 5岁[3-11],p= 0.001)和血红蛋白较低(眼部受累:6.68±2.31 g/dL vs. 8.46±2.47 g/dL, p= 0.01;视网膜出血:6.33±2.26 g/dL vs. 8.43±2.46 g/dL, p= 0.006)与较高的风险相关。在多变量模型中,年龄和Hb是出血的独立预测因子(年龄:比值比[OR] 1.29, 95%可信区间[CI] 1.10-1.52 /年;Hb:比值比[OR] 0.60, 95%可信区间[CI] 0.38-0.95 / g/dL)。ROC分析显示,年龄提供了最好的鉴别(曲线下面积[AUC] 0.796; 95% CI 0.651-0.940;临界值≥10岁:73%敏感性,70%特异性),其次是Hb (AUC 0.756; 95% CI 0.604-0.908;临界值6.95 g/dL:敏感性76%,特异性76%),而PLT的鉴别较弱(AUC 0.682; 95% CI 0.553-0.812;临界值48000 /mm³:敏感性62%,特异性65%)。结论:大约五分之一的儿童在诊断时有眼部受累,最常见的是视网膜出血。年龄和血红蛋白独立预测视网膜出血并提供有用的鉴别。这些数据支持“血红蛋白优先”的分类,即优先对年龄较大的儿童和血红蛋白≤7 g/dL的儿童进行初始和后续的眼底检测,并对所提出的阈值进行外部验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书